Navigation Links
Schering-Plough CEO to Buy $2 Million in Common Shares
Date:1/18/2008

KENILWORTH, N.J., Jan. 18 /PRNewswire-FirstCall/ -- Schering-Plough Corporation announced this morning that Chairman and CEO Fred Hassan intends to make an open market purchase of $2 million of Schering-Plough Common Shares with personal funds.

"As was the case in November 2003 when I purchased $4.68 million in Schering-Plough Common Shares at an average price of $15.42 (2003 press release below), this investment in Schering-Plough reflects my long-term confidence in the company, its products (including ZETIA and VYTORIN), and our late-stage pipeline," said Hassan. "The media interpretations of the top-line ENHANCE trial results, and the resulting stock price reaction, have been deeply troubling. I firmly believe in VYTORIN and ZETIA. Further, I believe this company is now a strong and diverse global competitor, with sound long- term fundamentals, that is capable of driving long-term growth. Our mission is 'To earn trust, every day,' and this personal stock purchase reflects my faith that, together, our 50,000 dedicated Schering-Plough employees can accomplish that mission."

Hassan had wanted to purchase the stock yesterday, when the stock closed at $21.62. However, it was determined that, under the federal securities laws, it would be better to defer the purchase until earnings for the fourth quarter and the full year 2007 are announced, scheduled for Feb. 12, 2008, and the full results of the ENHANCE trial are discussed in a scientific forum, anticipated for the American College of Cardiology meeting in late March. Hassan committed that the purchase will then be completed, whatever the stock price at that time. "I had already made a significant personal investment in Schering-Plough in 2003, and I believe that adding another $2 million to this personal investment is the right thing to do."

BELOW: 2003 PRESS RELEASE ON CEO STOCK PURCHASE

SCHERING-PLOUGH CEO BUYS $4.68 MILLION OF COMPANY COMMON STOCK

KENILWORTH, N
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
2. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
3. Schering-Plough Reports Financial Results for Third Quarter of 2007
4. Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment
5. Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case
6. Schering-Plough to Webcast CFO Robert J. Bertolinis Presentation at 2007 Credit Suisse Health Care Conference
7. Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
8. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
9. Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
10. Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
11. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)... finds more than 350 common sets of genes in patie...thDay News) -- Genetic activity in breast cancer c...s tend to more aggressive when they strike at a yo...younger women do worse than older women," said sen...of the clinical trials program in breast cancer at...
(Date:7/9/2008)...rtnership Integrates In-Store and Online Marketing...r Experience, PITTSBURGH and NEW YORK, July 9 /PR...on, ("GNC"), the largest global specialty retailer... ), the leading source of,health information, toda...increase consumer awareness and understanding of t...
(Date:7/9/2008)...ETHESDA, Md., July 9 /PRNewswire/ -- leViv, Inc. ...exclusively on nutrition and lifestyle programs fo...programs today. The new,programs include 28-days o...per day -- over 110 items in every order), online ...ucational resources, professional advice,news, he...
(Date:7/9/2008)...astfeeding.com adds to its unparalleled content on... Center,: 1400 professional articles on child, hea...s and sleep walking., BOULDER, Colo., July 9 /PRN...source with ,Everything for the New Mom, improves ...with over 1400 doctor-reviewed,professional articl...
Breaking Medicine News(10 mins):Health News:Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 2Health News:Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 3Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 3Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 2Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 3Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2
...e have discovered a tiny bacterium that could one ...phenyls (PCBs) from our environment//. The organis... detoxify commercial PCB compounds on site — witho... will appear in the April 15 issue of Applied and ...
...day has indicated the need for a cardiac departmen...cunae// in the care meted out to patients who have...kay Base Hospital. Mackay Base Hospital was found ...in 22 of the 26 categories but portrayed some worr...
...Hospital have discovered previously unsuspected mu...ric acute lymphoblastic leukemia (ALL), // the mos...y suggests novel methods for treating pediatric AL...ion of unsuspected mutations in adult cancers. &...
...im facts to state. The study estimates that more t...tism// and that it also takes more than two years ...n addition, around 125,000 Australians suffer from...d communication problems, social interaction and s...
Other Medicine News:Health News:Bacterium Could Treat PCBs Without the Need for Dredging 2Health News:Major Gene Study Uncovers Secrets of Leukemia 2Health News:Major Gene Study Uncovers Secrets of Leukemia 3
(Date:7/7/2008)...RIDGE, Mass., July 7 /- Bio...that it has had discussions with the Food,and Drug... patient,population for a new clinical trial of He... HBOC-201. Biopure has proposed to study use of He...s Leukemia (AML) who refuse,transfusion with blood...
(Date:7/7/2008)... New Study Suggests Kiwifruit is Top Performer in ... fruits are created equal when,it comes to their a...the,highest in bioavailability compared to other a...ll-scale study published in the Journal of the,Ame... vitamins and phytochemicals called flavonoids tha...
(Date:7/6/2008)... are basis for CTI,s Marketing Authorization Appli...ew by the EMEA, SEATTLE, July 7 /PRNewswire-First...TIC ; MTA) today announced the publication of resu...OPAXIO(TM) (paclitaxel poliglumex,CT-2103) with g...2,(performance status 2) patients with previously ...
(Date:7/3/2008)...VILLE, Md., July 3 /PRNewswire-USNewswire/ -- All ...hearing loss that is present at birth,according t...rvices Task,Force. The recommendation and the acco...issue of Pediatrics., Children whose hearing is i...hood can have problems with verbal and nonverbal c...
Breaking Medicine Technology:Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3Kiwifruit: Antioxidant Power in Quantity and Quality 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Many Patients Stop Taking Cholesterol Lowering Drugs 5781 1Many Patients Stop Taking Cholesterol Lowering Drugs 5781 2Dilon Technologies Explores Improvements in Molecular Breast Imaging 5779 1Dilon Technologies Explores Improvements in Molecular Breast Imaging 5779 2Dilon Technologies Explores Improvements in Molecular Breast Imaging 5779 3AMIAs 31st Annual Symposium Opens in Chicago IL 5777 1AMIAs 31st Annual Symposium Opens in Chicago IL 5777 2AMIAs 31st Annual Symposium Opens in Chicago IL 5777 3New Study Same Verdict 5775 1New Study Same Verdict 5775 2
...cal Data Presented at the Society for Investigativ...swire-FirstCall/ -- AGI,Dermatics today announced ...lycosylase (OGG1) encapsulated in liposomes,enhanc...V,irradiated skin cells. The data was presented at...igative Dermatology, May 9 - 12,in Los Angeles, C...
...GH, N.C.--(BUSINESS WIRE)--May 17, 2007 - Salix,Ph...that results of,18 investigator-initiated trials r... at Digestive Disease Week(R) 2007, which will be,...nsidered the,largest and most prestigious meeting ...t attracts more than 16,000 physicians,researcher...
Other Medicine Technology:AGI Dermatics Data Shows the 8 Oxo-Guanine Repair Enzyme OGG1,Encapsulated in Liposomes, Reduces MMP-1 and TNF-alpha in UV,Irradiated Skin Cells 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5
...0 provides a new screening, diagnostic, treatment ...the medical management of sleep-related breathing ...l the unmet need for an ambulatory, reliable, pati...cessible to the great number of OSA sufferers, and...
...ulin is the C-terminal cleavage product produced d...mature insulin molecule. Although the C-peptide of... significant liver or extra-renal metabolism and t...han insulin [1]. In addition, C-peptide assays may...
...7-Hydroxy-4-androstene-3-one), a C19 steroid, is o... [1]. In postpubertal males, testosterone is secre...nt derived from peripheral conversion of androsten...that over 50% of serum testosterone is derived fro...
...s the primary active hormone synthesized within th... synthesized via a series of steps involving: (i) ...nation of tyrosine residues in the thyroglobulin s...e and 3,5-diiodotyrosine (MIT and DIT), and (iii) ...
Medicine Products: